Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Inhibrx Biosciences, Inc
University of Pittsburgh
Bicara Therapeutics
Leap Therapeutics, Inc.
Intensity Therapeutics, Inc.
UNICANCER
Carisma Therapeutics Inc
Fate Therapeutics